BGPT: Author Review: Gema Moreno-Bueno

Explore by Goal

Quick Explanation Copied

Gema Moreno-Bueno — scientific impact snapshot

Across decades, her highly cited work centers on epithelial–mesenchymal transition (EMT), metastatic programs, and tumor microenvironment mechanisms, including classic mechanistic EMT/transcriptional regulation and microvesicle/exosome-mediated metastatic reprogramming.

Long Explanation

Author Review: Gema Moreno-Bueno

This review is evidence-weighted and skeptical: I focus on what the published literature (linked via DOI where available) supports mechanistically, where inferential steps are required, and what would disprove key claims.

Citation hygiene note (epistemic humility): you provided an OpenAlex-derived publication list and citation totals, but not the full-text experimental raw data for every listed item. Where I make specific mechanistic claims, I cite the relevant DOI papers you supplied (and I do not extrapolate beyond what those papers substantiate).

1) Visual impact & output over time (OpenAlex counts_by_year)

Works published per year (as provided)

Raw table (same series)

Year	Works count
1999	1
2000	3
2001	7
2002	4
2003	6
2004	7
2005	1
2006	10
2007	8
2008	12
2009	6
2010	6
2011	8
2012	8
2013	5
2014	14
2015	8
2016	16
2017	8
2018	5
2019	9
2020	7
2021	11
2022	11
2023	112
2024	14
2025	10

2) Research themes grounded in cited representative works

EMT transcriptional control & phenotypic mapping

The work on EMT transcriptional regulation of polarity/cell-state programing is explicitly framed as transcriptional logic linking EMT and cancer cell polarity programs ().
The EMT/basal-like linkage is supported by a direct association study and immunohistochemical phenotype mapping in breast cancer contexts ().
In parallel, Snail-family expression correlations with grade and lymph-node status provide a phenotypic risk gradient consistent with EMT-program activation in vivo human tissue cohorts ().

From EMT programs to metastatic biology

A key mechanistic claim in the field is that metastatic colonization may require repression of EMT-inducers to enable outgrowth. Moreno-Bueno co-authored work supporting that metastatic colonization can require repression of the EMT inducer Prrx1 ().

Tumor extracellular vesicles and metastatic microenvironment reprogramming

A hallmark contribution is exosome-mediated pro-metastatic bone marrow reprogramming: melanoma exosomes educate bone marrow progenitors toward a pro-metastatic phenotype through MET ().

Epigenetic/biomarker threads (example: MGMT liquid biopsy assays)

Your provided list includes EV-based MGMT methylation liquid biopsy work for glioblastoma management, and MGMT methylation assay clinical validation items. However, I do not have DOI links for those specific items in the data you supplied here, so I cannot responsibly make mechanistic/statistical claims about them with DOI-grade citation support.

3) How strong is the scientific chain? (what is known vs inferred)

Known (directly supported by cited work): correlation/association and mechanistic functional links are reported for EMT-linked transcriptional programs and for exosome-driven microenvironmental reprogramming through MET signaling (; ).
Inferred (requires careful boundary conditions): translating EMT marker associations into causation across all tumor contexts is risky. EMT is often measured with marker signatures, which can capture multiple related states rather than a single program; thus, the strongest claims need stage-specific functional tests (e.g., invasion vs colonization), reflected in the Prrx1 colonization repression concept ().

What would disprove or sharply weaken these themes?

For EMT-basal-like links: if marker correlations fail to hold in independent cohorts or fail causal perturbation tests under matched genetic/epigenetic backgrounds ().
For exosome→MET: if MET-dependence disappears when exosome cargo is controlled (e.g., genetic cargo ablation/denaturing of relevant exosome components) or if orthogonal assays contradict progenitor reprogramming ().

4) Citation-supported “representative paper triangulation”

Cited-by anchors (as provided by OpenAlex for the cited representative works)

Critical interpretation: high citation counts are suggestive of influence, but they do not guarantee correctness or mechanistic truth across contexts; they can reflect field relevance, review/consensus effects, or citation practices.

5) Scientific citation metrics (from provided OpenAlex / dataset)

OpenAlex top-profile: works_count 317, cited_by_count 18066, h_index 66 (profile: Gema Moreno‐Bueno with ORCID 0000-0002-5030-6687).
Additional provided metrics (your Author Citation Information block): h-index 64, total citations 15901, paper count 187 (note: these may differ due to dataset coverage and name-disambiguation effects).

Skeptical caution: name disambiguation can fragment or merge author identities; thus, metrics should be treated as approximations unless you verify author-id mapping across databases.

6) Blind spots / limitations / bias risks (scientific)

Over-generalization risk: EMT is heterogeneous and often context-dependent; association studies (e.g., Snail vs grade/nodes) must be complemented by stage-specific causality tests ().
Microenvironment cargo complexity: exosome phenotypes can be driven by multiple cargos and experimental isolation methods can bias composition. Even strong work like exosome→MET requires rigorous control of vesicle preparation and cargo specificity ().
Reproducibility uncertainty: without full-text methods and independent replication data in this prompt, I cannot assess assay robustness across labs; the safest stance is that these themes are promising but should be continuously stress-tested.
Publication/citation bias: influential mechanistic narratives may be preferentially cited; citation counts can overrepresent successful framing.

7) User-oriented next steps on BGPT

Feedback:

Updated: April 17, 2026

Key Insight

Stage-dependent EMT logic (EMT not uniformly “on” for metastasis) plus extracellular vesicle signaling suggests a model where metastasis requires switching between invasive plasticity and colonization-compatible states, with MET-axis microenvironment education acting as a parallel “switch” channel.

Keep Exploring

Which of Moreno-Bueno’s cited EMT papers most strongly establish causality (genetic/chemical perturbations with stage-resolved phenotyping) rather than correlation, and what controls are decisive?

How do her vesicle/metastasis works compare in cargo specificity: which experimental designs best separate vesicles vs soluble factors, and which show consistent MET dependence across models?

Can we map her publication network around EMT inducers (Snail/Slug/E47; Prrx1; LOXL2) into a mechanistic dependency graph with explicit falsifiable nodes?

Analysis Wizard

None—this author review is evidence-anchored; no user-uploaded data or sequence/omics files were provided to justify a bioinformatics computation.

Hypothesis Graveyard

A single EMT “master switch” universally governs both invasion and colonization would be disfavored by the colonization-specific repression logic for Prrx1 ().

A purely correlative EMT marker (e.g., Snail expression) would be weakened if causality cannot be established across matched models and stages; the Snail–grade/nodes evidence supports association but not universal causation ().

Potential Experiments

Stage-resolved perturbation: compare metastatic invasion vs colonization outputs after MET-pathway cargo perturbation in exosome-mediated bone marrow education models, quantifying vesicle composition and niche markers to test outgrowth specificity.

Coupled-state vesicle profiling: in matched breast cancer models, induce EMT programs that mimic Snail/E47-like transcriptional states vs enforce EMT inducer repression logic (Prrx1 axis), then test whether vesicle output composition predicts MET-dependent niche education capacity across stages.

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I prioritize mechanistic causality and method-level verifiability over citation counts, which can underweight influential but hard-to-audit observational work.

Stay current without chasing every paper.

Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.

Check Your Claims Before Reviewers Do

Verify your claims against versioned evidence records with exact reported results and sources.Know what the science actually supports before you trust the answer.